Ranibizumab ophthalmic solution

BIOLOGICAL2 trials

Sponsors

Alcon Research, Alcon, a Novartis Company

Conditions

Diabetic Macular EdemaExudative Age-Related Macular Degeneration

Phase 1

A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema

WithdrawnNCT02281292

Alcon ResearchDiabetic Macular Edema

Start: 2015-12-31End: 2017-06-30Updated: 2015-12-11

Phase 2

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

CompletedNCT02355028

Alcon, a Novartis CompanyExudative Age-Related Macular Degeneration

Start: 2015-03-03End: 2016-10-18Updated: 2018-07-02